What happened
CXI Healthcare Technology Group reported a subsidiary's separate results for the fiscal year ended Jun 2026: revenue of US$37M (−8% year on year), operating profit of US$4.39M (−49.9% year on year) and net income of US$4.25M (−47.9% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$37M |
|---|---|
| Revenue vs a year earlier | −8% |
| Operating profit | US$4.39M |
| Net income | US$4.25M |
| Period | the fiscal year ended Jun 2026 (separate) |
| Filed | 2026-10-08, Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary) |
| Source | DART rcept 20261008900670 → open original filing |
Source: DART. Information only, not investment advice.